National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, Maryland.
Department of Cell Biology and Physiology, Washington University School of Medicine , St. Louis, Missouri.
Am J Physiol Heart Circ Physiol. 2018 Jul 1;315(1):H18-H32. doi: 10.1152/ajpheart.00683.2017. Epub 2018 Mar 2.
Increased vascular stiffness correlates with a higher risk of cardiovascular complications in aging adults. Elastin (ELN) insufficiency, as observed in patients with Williams-Beuren syndrome or with familial supravalvular aortic stenosis, also increases vascular stiffness and leads to arterial narrowing. We used Eln mice to test the hypothesis that pathologically increased vascular stiffness with concomitant arterial narrowing leads to decreased blood flow to end organs such as the brain. We also hypothesized that drugs that remodel arteries and increase lumen diameter would improve flow. To test these hypotheses, we compared carotid blood flow using ultrasound and cerebral blood flow using MRI-based arterial spin labeling in wild-type (WT) and Eln mice. We then studied how minoxidil, an ATP-sensitive K channel opener and vasodilator, affects vessel mechanics, blood flow, and gene expression. Both carotid and cerebral blood flows were lower in Eln mice than in WT mice. Treatment of Eln mice with minoxidil lowered blood pressure and reduced functional arterial stiffness to WT levels. Minoxidil also improved arterial diameter and restored carotid and cerebral blood flows in Eln mice. The beneficial effects persisted for weeks after drug removal. RNA-Seq analysis revealed differential expression of 127 extracellular matrix-related genes among the treatment groups. These results indicate that ELN insufficiency impairs end-organ perfusion, which may contribute to the increased cardiovascular risk. Minoxidil, despite lowering blood pressure, improves end-organ perfusion. Changes in matrix gene expression and persistence of treatment effects after drug withdrawal suggest arterial remodeling. Such remodeling may benefit patients with genetic or age-dependent ELN insufficiency. NEW & NOTEWORTHY Our work with a model of chronic vascular stiffness, the elastin ( Eln) mouse, shows reduced brain perfusion as measured by carotid ultrasound and MRI arterial spin labeling. Vessel caliber, functional stiffness, and blood flow improved with minoxidil. The ATP-sensitive K channel opener increased Eln gene expression and altered 126 other matrix-associated genes.
血管僵硬度增加与老年人心血管并发症风险升高相关。弹性蛋白(ELN)不足,如在威廉姆斯-贝伦综合征或家族性主动脉瓣上狭窄患者中观察到的那样,也会增加血管僵硬度并导致动脉变窄。我们使用 Eln 小鼠来测试以下假设:病理性增加的血管僵硬度伴随着动脉狭窄会导致大脑等终末器官的血流减少。我们还假设,重塑动脉和增加管腔直径的药物将改善血流。为了验证这些假设,我们使用超声比较了野生型(WT)和 Eln 小鼠的颈动脉血流量,并使用基于 MRI 的动脉自旋标记比较了脑血流量。然后,我们研究了米诺地尔(一种 ATP 敏感性钾通道开放剂和血管扩张剂)如何影响血管力学、血流和基因表达。与 WT 小鼠相比,Eln 小鼠的颈动脉和脑血流量均较低。用米诺地尔治疗 Eln 小鼠可降低血压并将功能性动脉僵硬度降低至 WT 水平。米诺地尔还改善了 Eln 小鼠的动脉直径并恢复了颈动脉和脑血流量。停药数周后,有益效果仍持续存在。RNA-Seq 分析显示,治疗组之间有 127 个细胞外基质相关基因的差异表达。这些结果表明,ELN 不足会损害终末器官灌注,这可能导致心血管风险增加。尽管米诺地尔降低血压,但可改善终末器官灌注。基质基因表达的变化和停药后治疗效果的持续存在表明动脉重塑。这种重塑可能有益于具有遗传或年龄依赖性 ELN 不足的患者。
我们使用慢性血管僵硬模型(Eln 小鼠)的工作表明,颈动脉超声和 MRI 动脉自旋标记测量的脑灌注减少。米诺地尔可改善血管口径、功能僵硬度和血流。ATP 敏感性钾通道开放剂增加了 Eln 基因表达并改变了 126 个其他与基质相关的基因。